Page 97 - The role of advanced echocardiography in patients with ischemic heart disease - Rachid Abou

Table 1. Baseline characteristics of the study population
Variable
Total population (n=502)
No adverse remodeling (n=321)
Adverse remodeling (n=181)
p-value
Clinical characteristics
Age (years)
BSA (m2)
Male gender, n (%)
Systolic blood pressure (mmHg) Diastolic blood pressure(mmHg) Heart rate discharge (bpm)
Cardiovascular risk factors
Hypertension, n (%) Hypercholesterolemia, n (%) Family history of CAD, n (%) Diabetes mellitus, n (%) Current smoker, n (%)
Biochemical markers
Peak CPK (U/L)
Peak cTnT (μg/L) eGFR (ml/min/1.73m2) Glucose (mmol/L)
Coronary angiography
Killip class ≥ 2, n (%) Culprit vessel
RCA, n (%)
Left main, n (%) LAD, n (%)
LCX, n (%)
Multi-vessel disease, n (%)
60 ± 11 2.0 ± 0.2 382 (76) 136 ± 24 81 ± 15 70 ± 13
141 (28)
98 (20) 215 (43) 43 (9) 251 (50)
1794 (901-3180)
4.9 (2.2-9.7) 95 ± 30 8.1 (6.8-9.7)
24 (5)
189 (38) 1 (0) 269 (54) 79 (16) 228 (45)
60 ± 11 2.0 ± 0.2 248 (77) 136 ± 23 82 ± 15 69 ± 12
89 (28) 63 (20) 138 (43)
22 (7) 162 (51)
1652 (830-2866)
4.4 (1.8-8.0) 96 ± 30 7.9 (6.5-9.4)
12 (4)
124 (39) 1 (0) 179 (56) 54 (17) 144 (45)
61 ± 12 1.9 ± 0.2 134 (74) 136 ± 24 80 ± 15 73 ± 15
52 (29) 35 (19) 77 (43) 21 (12) 89 (49)
2079 (1198-4038)
5.9 (2.8-10.7) 94 ± 30 8.5 (7.2-10.2)
12 (7)
65 (36) 0 (0) 90 (50) 25 (14) 84 (46)
0.354 0.066 0.446 0.419 0.169 <0.001
0.810 5 0.937
0.922
0.068
0.780
0.001
<0.001 0.481 0.001
0.145
0.546 0.452 0.193 0.351 0.738
Data are presented as mean ± standard deviation, number (percentage) or as median (25th-75th percentile). BSA = body surface area; bpm = beats per minute; CAD = coronary artery disease; CPK = creatine phosphokinase; cTnT = cardiac troponin T; (e)GFR = glomerular filtration rate esti- mated with the Cockcroft-Gault formula; LAD = left anterior descending coronary artery; LCX=left circumflex artery; RCA= right coronary artery. Hypertension was defined as office blood pressure ≥140/90 mm Hg or previous pharmacological treatment. Hypercholesterolemia was defined as total cholesterol 190 mg/dl or previous pharmacological treatment. Diabetes mellitus was defined as fasting blood glucose ≥7.0 mmol/L, 2-h oral glucose tolerance test glucose ≥11.1 mmol/L or pre- vious pharmacological treatment. Multi-vessel disease was defined as the presence >1 vessel with luminal narrowing ≥50%. p-values are presented for the comparisons between different groups.
91